Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Editorial team
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience Specialist pharmaceutical experience strengthens Symbiosis’ international growth ambitions Virginie Cavalli appointed Chief Executive Officer of Seppic Virginie Cavalli appointed Chief Executive Officer of Seppic Virginie Cavalli appointed Chief Executive Officer of Seppic Seppic announces the appointment of Virginie Cavalli as Chief Executive Officer, effective September 1, 2026 Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG Wolf Lehmann, CFO, and Achim Schalk, Member of the Management Board, will assume his duties until further notice Symbiosis strengthens commercial team with appointment of Jay Chima Symbiosis strengthens commercial team with appointment of Jay Chima Symbiosis strengthens commercial team with appointment of Jay Chima Symbiosis appoints Jay Chima as vice president, business development, to support growth and strengthen partnerships across the pharmaceutical and biotechnology sectors Lonza appoints Samanta Cimitan as chief commercial officer Lonza appoints Samanta Cimitan as chief commercial officer Lonza appoints Samanta Cimitan as chief commercial officer Newly created role will strengthen customer engagement, commercial delivery and a harmonised go-to-market approach across One Lonza Piramal Pharma completes acquisition of controlling stake in Yapan Bio Piramal Pharma completes acquisition of controlling stake in Yapan Bio Piramal Pharma completes acquisition of controlling stake in Yapan Bio Acquisition strengthens Piramal’s biologics capabilities and integrated large molecule CDMO offering Anders Fogelberg appointed president and CEO of BICO Group AB Anders Fogelberg appointed president and CEO of BICO Group AB Anders Fogelberg appointed president and CEO of BICO Group AB BICO appoints current Chief Commercial Officer Anders Fogelberg as President and CEO, effective September 1, 2026 Pace appoints Andy Fenny as President of Pace Life Sciences Pace appoints Andy Fenny as President of Pace Life Sciences Pace appoints Andy Fenny as President of Pace Life Sciences Experienced life sciences executive brings more than 20 years of CDMO and pharmaceutical leadership to drive strategic growth Clinilabs announces leadership expansion Clinilabs announces leadership expansion Clinilabs announces leadership expansion Laura Shannon joins the organisation as Chief Executive Officer while Gary Zammit, the Company’s founder, assumes the role of Executive Chairperson As new CTO, Christian Reichardt is driving the technological advancement of Optima Pharma As new CTO, Christian Reichardt is driving the technological advancement of Optima Pharma As new CTO, Christian Reichardt is driving the technological advancement of Optima Pharma This investment is driven by growth areas such as biologics, GLP-1 products, and other sterile pharmaceuticals, as well as the increasing demand for isolator and high-potency... Reacta Healthcare appoints Iedena Lima as head of research and development Reacta Healthcare appoints Iedena Lima as head of research and development Reacta Healthcare appoints Iedena Lima as head of research and development Extensive pharma and medtech sector experience strengthens senior leadership to support growth and strategic expansion Clinilabs announces medical leadership appointments Clinilabs announces medical leadership appointments Clinilabs announces medical leadership appointments Bob Dagher, M.D., named chief medical officer and Waqar Ahmed Siddiqui, M.D., named principal investigator FUJIFILM Biotechnologies transitions leadership to drive next phase of operational excellence FUJIFILM Biotechnologies transitions leadership to drive next phase of operational excellence FUJIFILM Biotechnologies transitions leadership to drive next phase of operational excellence FUJIFILM Biotechnologies today announced a planned leadership evolution as the Company enters its next phase of execution and sustainable growth Fresenius Medical Care appoints Cassie McLean as Management Board member for Care Delivery Fresenius Medical Care appoints Cassie McLean as Management Board member for Care Delivery Fresenius Medical Care appoints Cassie McLean as Management Board member for Care Delivery Cassie McLean succeeds Craig Cordola as CEO of Care Delivery, effective 1 August 2026 IMCD appoints Vlad Miller as president, US IMCD appoints Vlad Miller as president, US IMCD appoints Vlad Miller as president, US Vlad Miller takes on the role of President, US, following five months leading the business on an interim basis Actimed strengthens board with appointment of Dr Anders Ullman Actimed strengthens board with appointment of Dr Anders Ullman Actimed strengthens board with appointment of Dr Anders Ullman Pharmaceutical executive brings more than 30 years of international drug development and corporate leadership experience
  • Previous
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 215
  • Next

Trending Articles

  1. DFE Pharma appoints Khatera Alawi as new Global Director Human Resources An experienced international HR leader, Alawi joins DFE Pharma’s Leadership Team to support the company’s people-centric, high-performance culture
  2. Lonza appoints Samanta Cimitan as chief commercial officer Newly created role will strengthen customer engagement, commercial delivery and a harmonised go-to-market approach across One Lonza
  3. Pace appoints Andy Fenny as President of Pace Life Sciences Experienced life sciences executive brings more than 20 years of CDMO and pharmaceutical leadership to drive strategic growth
  4. Virginie Cavalli appointed Chief Executive Officer of Seppic Seppic announces the appointment of Virginie Cavalli as Chief Executive Officer, effective September 1, 2026
  5. Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG Wolf Lehmann, CFO, and Achim Schalk, Member of the Management Board, will assume his duties until further notice

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.